| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30018203 | HIV | ENSG00000170634.13 | protein_coding | ACYP2 | No | No | 98 | P14621 U3KQL2 |
| TVIS30085042 | HIV | ENSG00000170634.13 | protein_coding | ACYP2 | No | No | 98 | P14621 U3KQL2 |
| TVIS30050302 | HIV | ENSG00000170634.13 | protein_coding | ACYP2 | No | No | 98 | P14621 U3KQL2 |
| TVIS30050303 | HIV | ENSG00000170634.13 | protein_coding | ACYP2 | No | No | 98 | P14621 U3KQL2 |
| TVIS30050304 | HIV | ENSG00000170634.13 | protein_coding | ACYP2 | No | No | 98 | P14621 U3KQL2 |
| TVIS30050305 | HIV | ENSG00000170634.13 | protein_coding | ACYP2 | No | No | 98 | P14621 U3KQL2 |
| TVIS30050306 | HIV | ENSG00000170634.13 | protein_coding | ACYP2 | No | No | 98 | P14621 U3KQL2 |
| TVIS20001655 | HPV | ENSG00000170634.13 | protein_coding | ACYP2 | No | No | 98 | P14621 U3KQL2 |
| TVIS20064916 | HPV | ENSG00000170634.13 | protein_coding | ACYP2 | No | No | 98 | P14621 U3KQL2 |
| TVIS20054256 | HPV | ENSG00000170634.13 | protein_coding | ACYP2 | No | No | 98 | P14621 U3KQL2 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ACYP2 |
|---|---|
| DrugBank ID | DB01942 |
| Drug Name | Formic acid |
| Target ID | BE0004569 |
| UniProt ID | P14621 |
| Regulation Type | |
| PubMed IDs | 10592235 |
| Citations | Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
| Groups | Experimental; Investigational |
| Direct Classification | Carboxylic acids |
| SMILES | [H]C(O)=O |
| Pathways | Cerivastatin Action Pathway; Desmosterolosis; Pamidronate Action Pathway; Ibandronate Action Pathway; 17-beta Hydroxysteroid Dehydrogenase III Deficiency; DOPA-Responsive Dystonia; Simvastatin Action Pathway; Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2); Smith-Lemli-Opitz Syndrome (SLOS); Pterine Biosynthesis; Lysosomal Acid Lipase Deficiency (Wolman Disease); Steroid Biosynthesis; Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps); Hypercholesterolemia; Risedronate Action Pathway; Hyperphenylalaniemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency; Mevalonic Aciduria; Tryptophan Metabolism; Rosuvastatin Action Pathway; Alendronate Action Pathway; Zoledronate Action Pathway; Cholesteryl Ester Storage Disease; Androgen and Estrogen Metabolism; Lovastatin Action Pathway; Folate Metabolism; Aromatase Deficiency; Methylenetetrahydrofolate Reductase Deficiency (MTHFRD); Fluvastatin Action Pathway; Atorvastatin Action Pathway; Pravastatin Action Pathway |
| PharmGKB | PA449705 |
| ChEMBL | CHEMBL116736 |
